Literature DB >> 17100883

Taking license with natural killer cell maturation and repertoire development.

Peter Parham1.   

Abstract

Combining population analysis with in-depth analysis of selected individuals, the tolerance of human natural killer (NK) cells to autologous major histocompatibility complex (MHC) class I and potential reactivity to allogeneic MHC class I have been studied. Analysis of NK cell clones in long-term culture and peripheral blood NK cells after short-term culture (20-24 h) shows that NK cell tolerance is determined by interactions of autologous MHC class I with CD94:NKG2A and inhibitory killer cell immunoglobulin-like receptors (KIRs). Alloreactivity is predicted whenever the donor of the allogeneic target lacks a cognate MHC class I-KIR, ligand-receptor pair that is present in the NK cell donor. In the human population, there is a wide variation in the NK cell repertoire of KIRs and CD94:NKG2A expression. Variation is principally due to KIR gene variation and polymorphism, with a smaller effect due to MHC class I. The presence of MHC class I increases the frequency of NK cells expressing the cognate KIR, an effect that is diminished by the presence of other cognate-ligand pairs. The minor influence of MHC class I on the KIR repertoire indicates that NK cell development is an efficient process in which the expression of inhibitory MHC class I receptors at the final stages ensures that functionally active human NK cells are self-tolerant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100883     DOI: 10.1111/j.1600-065X.2006.00462.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  29 in total

Review 1.  Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.

Authors:  James O J Davies; Kate Stringaris; A John Barrett; Katayoun Rezvani
Journal:  Cytotherapy       Date:  2014-05-20       Impact factor: 5.414

2.  Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer.

Authors:  Suliman Y Al Omar; Ernie Marshall; Derek Middleton; Stephen E Christmas
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

3.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

4.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Authors:  Frank Cichocki; Rebecca J Hanson; Todd Lenvik; Michelle Pitt; Valarie McCullar; Hongchuan Li; Stephen K Anderson; Jeffrey S Miller
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

5.  Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.

Authors:  Anna Kruschinski; Andreas Moosmann; Isabel Poschke; Håkan Norell; Markus Chmielewski; Barbara Seliger; Rolf Kiessling; Thomas Blankenstein; Hinrich Abken; Jehad Charo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

6.  NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.

Authors:  Vivien Béziat; Benjamin Descours; Christophe Parizot; Patrice Debré; Vincent Vieillard
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

7.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

Review 8.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

Review 9.  Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses.

Authors:  Saar Gill; Janelle A Olson; Robert S Negrin
Journal:  Biol Blood Marrow Transplant       Date:  2009-04-02       Impact factor: 5.742

10.  Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.

Authors:  Gal Markel; Rachel Seidman; Michal J Besser; Naama Zabari; Rona Ortenberg; Ronnie Shapira; Avraham J Treves; Ron Loewenthal; Arie Orenstein; Arnon Nagler; Jacob Schachter
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.